The MAT recommends the State of NM work with Gilead, the manufacturer of Remdesivir to obtain approval for University of NM Hospital and Presbyterian to participate in clinical trials for COVID-19

The MAT recommends the State of NM work with Gilead, the manufacturer of Remdesivir to obtain approval for University of NM Hospital and Presbyterian to participate in clinical trials for COVID-19; however, availability of Remdesivir is very limited and therefore...

To maximize the supply of Personal Protective Equipment (PPE), especially N95-type respirators, the MAT recommends NM acute care and ambulatory facilities implement structures and policies for the recycling of N95-type respirators

To maximize the supply of Personal Protective Equipment (PPE), especially N95-type respirators, the MAT recommends NM acute care and ambulatory facilities implement structures and policies for the recycling of N95-type respirators. The MAT recommends the use of...

The MAT recommends NM hospitals develop policies and procedures directing health care professionals to prioritize Personal Protective Equipment (PPE) for those in direct care of COVID-19 positive patients and Patients Under Investigation (PUIs)

The MAT recommends NM hospitals develop policies and procedures directing health care professionals to prioritize Personal Protective Equipment (PPE) for those in direct care of COVID-19 positive patients and Patients Under Investigation (PUIs), focusing reusable PPE...